中国实用外科杂志 ›› 2024, Vol. 44 ›› Issue (12): 1371-1374.DOI: 10.19538/j.cjps.issn1005-2208.2024.12.11

• 专题笔谈 • 上一篇    下一篇

感染性腹主动脉瘤合并消化道瘘的外科治疗

郑月宏,李斯亭   

  1. 中国医学科学院北京协和医学院血管外科 中国医学科学院北京协和医院疑难重症及罕见病国家重点实验室,北京100730
  • 出版日期:2024-12-01 发布日期:2024-12-24

  • Online:2024-12-01 Published:2024-12-24

摘要: 原发性感染性主动脉瘤(INAA)是由病原微生物感染引起主动脉壁破坏及扩张的疾病,可引发原发性主动脉-消化道瘘,导致危及生命的消化道大出血,需要紧急外科干预。INAA的外科治疗包括开放手术(OSR)和腔内修复术(EVAR)。OSR通过清除感染组织并重建血运,被认为是金标准,但创伤较大;而EVAR创伤较小,但可能无法完全清除感染。合并消化道瘘的INAA治疗需根据病人感染情况、病变范围及病原特点制定个性化方案。OSR手术方式包括解剖外旁路重建和原位重建,解剖外旁路能彻底清除感染灶,而原位重建具有生理解剖优势,但可能遗留感染灶。近年来,EVAR在不稳定病人中的紧急应用为后续开放手术创造了条件。治疗效果的关键在于充分有效的围手术期及长期抗生素治疗,以降低感染复发风险。多种治疗方法均有成功病例报道,但关于最佳治疗策略的高质量临床证据仍然不足。INAA治疗需综合考虑病人的病理特点及临床状况,为感染性腹主动脉瘤合并消化道瘘提供最佳临床处理方案。

关键词: 感染性腹主动脉瘤, 消化道瘘, 开放手术, 腔内修复术, 围手术期抗生素, 解剖外旁路, 原位重建

Abstract: Infective native aortic aneurysm(INAA) is a condition characterized by the destruction and dilation of the aortic wall caused by pathogenic microorganism infection, which may lead to primary aorto-enteric fistula and life-threatening gastrointestinal hemorrhage, requiring urgent surgical intervention. Surgical treatment options for INAA include open surgical repair (OSR) and endovascular aneurysm repair (EVAR). OSR, which involves debridement of infected tissue and revascularization, is considered the gold standard but is associated with significant surgical trauma. In contrast, EVAR is less invasive but may not completely eradicate the infection. The treatment of INAA with concurrent aorto-enteric fistula requires an individualized approach based on the patient’s infection status, extent of the lesion, and microbial characteristics. OSR techniques include extra-anatomic bypass and in situ reconstruction. Extra-anatomic bypass allows complete removal of the infected lesion, while in situ reconstruction offers physiological and anatomical advantages but may leave residual infection. In recent years, the emergent use of EVAR in hemodynamically unstable patients has been shown to stabilize their condition and facilitate subsequent open surgery. The success of treatment relies heavily on effective perioperative and long-term antibiotic therapy to reduce the risk of infection recurrence. Although various treatment strategies have been reported as successful in case studies, high-quality clinical evidence on the optimal treatment approach remains limited. The management of INAA requires careful consideration of the patient’s pathological characteristics and clinical condition to provide the best clinical approach for treating infectious abdominal aortic aneurysm with concurrent aorto-enteric fistula.

Key words: infective native abdominal aortic aneurysm, gastrointestinal fistula, open surgery, endovascular repair, perioperative antibiotics, extra-anatomic bypass, in-situ reconstruction